España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Hyperfine
HYPR
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.9855
0.04
3.74%
At close: -
$0.9800
-0.00550
-0.56%
After Hours: Jan 24, 9:25 AM EDT
Get Report
Comment
Hyperfine (HYPR) Forecast
News
Earnings
Hyperfine (HYPR) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Hyperfine (NASDAQ:HYPR) Stock
Hyperfine Stock (NASDAQ: HYPR)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, December 05, 2024
Hyperfine Announces Extensive Clinical Study ...
Benzinga Newsdesk
Thursday, November 21, 2024
Hyperfine Swoop Portable MR Brain Imaging Sys...
Benzinga Newsdesk
Tuesday, November 19, 2024
Hyperfine Announces 10 Abstracts At RSNA, Hig...
Benzinga Newsdesk
Tuesday, November 12, 2024
Hyperfine Q3 2024 GAAP EPS $(0.14), Inline, S...
Benzinga Newsdesk
Hyperfine Narrows FY2024 Sales Guidance from ...
Benzinga Newsdesk
Earnings Scheduled For November 12, 2024
Benzinga Insights
Thursday, November 07, 2024
Hyperfine Announces CE Approval Of Its Swoop ...
Benzinga Newsdesk
Thursday, October 31, 2024
Hyperfine Unveils Alzheimer's Research At CTA...
Benzinga Newsdesk
Tuesday, October 01, 2024
Hyperfine Swoop Portable MR Imaging System Us...
Benzinga Newsdesk
Monday, September 23, 2024
Hyperfine's Portable Swoop MR Imaging System ...
Benzinga Newsdesk
Wednesday, September 11, 2024
Hyperfine Announced A Collaboration With The ...
Benzinga Newsdesk
Thursday, August 08, 2024
Hyperfine Sees FY24 Revenue $13M-$16M Vs $13....
Benzinga Newsdesk
Hyperfine Q2 2024 GAAP EPS $(0.14), Inline, S...
Benzinga Newsdesk
Tuesday, July 30, 2024
Hyperfine To Present Initial Data From Observ...
Benzinga Newsdesk
Wednesday, July 17, 2024
Hyperfine Announces FDA Clearance Of Software...
Benzinga Newsdesk
Monday, July 15, 2024
Hyperfine's Portable MRI As Tissue Clock For ...
Benzinga Newsdesk
Tuesday, June 25, 2024
Hyperfine's Clinical Research Using Swoop Sys...
Benzinga Newsdesk
Tuesday, May 28, 2024
Why You Should Bet on 5 Top-Ranked Stocks With Rising P/E
Zacks
Hyperfine Enters Distribution Partnership Wit...
Benzinga Newsdesk
Monday, May 13, 2024
Hyperfine Expects FY24 Revenue To Be $12M-$15...
Benzinga Newsdesk
Hyperfine Q1 2024 GAAP EPS $(0.14) Beats $(0....
Benzinga Newsdesk
Friday, May 10, 2024
Hyperfine Enters Agreements With Distributors...
Benzinga Newsdesk
Tuesday, April 23, 2024
Hyperfine Announced The Acceptance Of Sevente...
Benzinga Newsdesk
Wednesday, April 17, 2024
Hyperfine Enrolls First Alzheimer's Patients ...
Benzinga Newsdesk
Thursday, March 21, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Recap: Hyperfine Q4 Earnings
Benzinga Insights
Hyperfine Q4 EPS $(0.15) Beats $(0.18) Estima...
Benzinga Newsdesk
Earnings Scheduled For March 21, 2024
Benzinga Insights
Wednesday, March 20, 2024
Hyperfine Earnings Preview
Benzinga Insights
Wednesday, February 21, 2024
Hyperfine, Inc. Announces Collaboration With ...
Benzinga Newsdesk
Friday, January 12, 2024
Why VCI Global Shares Are Trading Lower By Around 30%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Tuesday, January 09, 2024
Hyperfine Launches AI-Powered Brain Imaging S...
Benzinga Newsdesk
Thursday, November 30, 2023
Jefferies Initiates Coverage On Hyperfine wit...
Benzinga Newsdesk
Monday, November 20, 2023
Hyperfine, Inc. Announces Presentations On Cl...
Benzinga Newsdesk
Friday, November 10, 2023
Hyperfine shares are trading lower after the ...
Benzinga Newsdesk
Thursday, November 09, 2023
Hyperfine Expects FY23 Revenue $11M-$13M
Benzinga Newsdesk
Recap: Hyperfine Q3 Earnings
Benzinga Insights
Hyperfine Q3 2023 Gaap EPS $(0.15) Beats $(0....
Benzinga Newsdesk
Earnings Scheduled For November 9, 2023
Benzinga Insights
Thursday, November 02, 2023
Observational Study Finds That Hyperfine Port...
Benzinga Newsdesk
Monday, October 09, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Hyperfine, Inc. Receives FDA Clearance For Up...
Bill Haddad
Wednesday, September 06, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Tuesday, August 15, 2023
B. Riley Securities Maintains Buy on Hyperfin...
Benzinga Newsdesk
Monday, August 14, 2023
Hyperfine Q2 EPS $(0.15) Beats $(0.16) Estima...
Benzinga Newsdesk
Earnings Scheduled For August 14, 2023
Benzinga Insights
Tuesday, July 25, 2023
Chief Operating Officer at Hyperfine Acquires Company Stock Options Worth 200,000 Shares
Benzinga Insights
Wednesday, July 19, 2023
Hyperfine Has Received A Decision To Grant European Patent Number EP3837636 Titled "Deep Learning Techniques For Suppressing Artefacts In Magnetic Resonance Images".
Happy Mohamed
Tuesday, July 18, 2023
Hyperfine Announces Promotion of Tom Teisseyr...
Benzinga Newsdesk
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
